When Chalmers two competence centres Chase and GigaHertz Centre summarize ten years of operation and stake out the direction for the future, both companies and Vinnova want to be on-board.
Copyright restrictions and an inflexible publisher licensing system are making European researchers hesitant to attempt analyses of large and disparate databases, according to Lisbon Council report
Science ministers tell publishers to ditch subscriptions and change their business models, but agree there should be caveats on open access to protect intellectual property rights, security and privacy
Taking money from Horizon 2020 has contributed to falling success rates in grant applications. The €2.2B funnelled to the Strategic Investment Fund should be restored to the programme in the budget review, say MEPs on the research committee
Six ESADE researchers have been recognised by Emerald Publishing, the owner of more than 300 scientific journals, for the quality and impact of their publications.
47 economists from the UCL Department of Economics, ranked first in the 2014 Research Excellence Framework, have added their voices to a warning that the economic costs of Brexit would be high.
The EU still has not learned basic lessons about innovation from its US competition. Professors Gunnar Landgren and Ramon Wyss, both instrumental in the formation of EIT Knowledge and Innovation Communities, explain how to remedy the European innovation paradox
Harvard economist Michael Porter argues that, to improve performance, healthcare systems need to measure not what goes in, but what comes out. A movement to focus more on such ‘patient outcomes’ is gathering speed in Europe
The world needs a global plan to tackle antimicrobial resistance. Alongside a $2B fund to jump-start innovation there should be a $1B reward for companies when a new antibiotic is launched, says Jim O’Neill, chair of the review
The new body will absorb seven research councils, covering all scientific disciplines, and the innovation agency Innovate UK, with the aim of creating integrated funding system
A new analysis says EU’s €3.3B pre-competitive drug research programme is delivering highly-rated science, levering in private money and creating new partnerships. But the full socio-economic benefits are yet to come
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.